Literature DB >> 25328063

Synthesis, Molecular Modeling, and Biological Evaluation of Novel 1, 3-Diphenyl-2-propen-1-one Based Pyrazolines as Anti-inflammatory Agents.

Syed Nasir Abbas Bukhari1, Xin Zhang2, Ibrahim Jantan1, Hai-Liang Zhu2, Muhammad Wahab Amjad1, Vijay H Masand3.   

Abstract

A novel series of 1,3-diphenyl-2-propen-1-one (chalcone) derivatives was synthesized by a simple, eco-friendly, and efficient Claisen-Schmidt condensation reaction and used as precursors for the synthesis of new pyrazoline derivatives. All the synthesized compounds were screened for anti-inflammatory related activities such as inhibition of phospholipase A(2) (PLA(2)), cyclooxygenases (COX-1 and COX-2), IL-6, and TNF-α. The results of the above studies show that the compounds synthesized are effective inhibitors of above pro-inflammatory enzymes and cytokines. Overall, the results of the studies reveal that the pyrazolines with chlorophenyl substitution (1b-6b) seem to be important for inhibition of enzymes and cytokines. Molecular docking experiments were performed to clarify the molecular aspects of the observed COX-inhibitory activities of the investigated compounds.
© 2014 John Wiley & Sons A/S.

Entities:  

Keywords:  Claisen-Schmidt condensation; arachidonic acid; chalcones; flavonoids; lipopolysaccharides

Mesh:

Substances:

Year:  2014        PMID: 25328063     DOI: 10.1111/cbdd.12457

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  3 in total

1.  Synthesis and Characterization of Dihydrouracil Analogs Utilizing Biginelli Hybrids.

Authors:  Syed Nasir Abbas Bukhari; Hasan Ejaz; Mervat A Elsherif; Nenad Janković
Journal:  Molecules       Date:  2022-05-04       Impact factor: 4.927

2.  Synthesis and evaluation of new chalcones and oximes as anticancer agents.

Authors:  Syed Nasir Abbas Bukhari
Journal:  RSC Adv       Date:  2022-04-01       Impact factor: 3.361

3.  Diverse Molecular Targets for Chalcones with Varied Bioactivities.

Authors:  Bo Zhou; Chengguo Xing
Journal:  Med Chem (Los Angeles)       Date:  2015-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.